Mansfield Elise, Bryant Jamie, Carey Mariko, Turon Heidi, Henskens Frans, Grady Alice
Health Behaviour Research Collaborative, School of Medicine and Public Health, Faculty of Health and Medicine University of Newcastle Callaghan Australia.
Priority Research Centre for Health Behaviour University of Newcastle Callaghan Australia.
Health Sci Rep. 2018 Nov 6;2(1):e101. doi: 10.1002/hsr2.101. eCollection 2019 Jan.
While cancer patients' preferences for their level of involvement in treatment decision making (TDM) vary, previous research indicates a large proportion of patients are not experiencing TDM that meets their preferences. Evidence is needed to identify the characteristics of cancer patients who are less likely to report experiencing their preferred level of involvement in TDM, so that appropriate decision-making support can be provided to them. We examined in a sample of medical oncology outpatients (1) the level of agreement between preferred and perceived involvement in TDM and (2) demographic, psychological, disease, and treatment characteristics associated with having unmet preferences for involvement in TDM.
Cancer patients from three medical oncology treatment centers in Australia completed surveys assessing demographic, disease and treatment variables, psychological distress, and preferred and perceived involvement in TDM. Data were collected between February 2013 and December 2014. Factors associated with having unmet TDM preferences were examined using logistic regression. There were 355 patients included in the analysis (75% response rate). The mean age (±SD) of the participants was 61 (±12), and 45% were male. Overall, 60% of participants reported that their preferences for involvement in TDM were met. No demographic, psychological, disease, or treatment characteristics were significantly associated with an increased probability of not having TDM preferences met.
In line with previous research, a large proportion (40%) of patients reported TDM experiences that were not in alignment with their preferences. Future research should explore additional characteristics that are associated with a lower likelihood of having TDM preferences met.
虽然癌症患者对参与治疗决策(TDM)程度的偏好各不相同,但先前的研究表明,很大一部分患者并未经历符合其偏好的TDM。需要证据来确定不太可能报告经历其偏好的TDM参与程度的癌症患者的特征,以便为他们提供适当的决策支持。我们在一组医学肿瘤门诊患者样本中研究了以下两点:(1)TDM中偏好的与感知到的参与程度之间的一致程度;(2)与TDM参与偏好未得到满足相关的人口统计学、心理、疾病和治疗特征。
来自澳大利亚三个医学肿瘤治疗中心的癌症患者完成了调查,评估人口统计学、疾病和治疗变量、心理困扰以及TDM中偏好的与感知到的参与程度。数据收集于2013年2月至2014年12月之间。使用逻辑回归分析与TDM偏好未得到满足相关的因素。分析纳入了355名患者(回复率为75%)。参与者的平均年龄(±标准差)为61(±12)岁,45%为男性。总体而言,60%的参与者报告他们对TDM参与的偏好得到了满足。没有人口统计学、心理、疾病或治疗特征与TDM偏好未得到满足的可能性增加显著相关。
与先前的研究一致,很大一部分(40%)患者报告的TDM经历与其偏好不一致。未来的研究应探索与TDM偏好得到满足的可能性较低相关的其他特征。